Aditya Birla Sun Life Pharma and Healthcare Fund - Regular Plan - Growth
NAV
₹35.52
as of 2026-10-01
Price History (NAV)
Performance Metrics (3 Year)
3Y CAGR
19%
Category avg 18.4%
Fund size
₹739 Cr
Assets under management
Sharpe
1.02
Risk-adjusted return (3Y)
Max drawdown
6.0%
Peak-to-trough decline (3Y)
Beta
0.76
Market sensitivity (3Y)
SIP / returns estimator
Estimation is based on the past performance of this fund
Total Corpus After 7 Year(s)
@12.0% p.a. returns
₹4.20 L
+₹2.40 L
Fund FAQs
Frequently asked questions about Aditya Birla Sun Life Pharma and Healthcare Fund - Regular Plan - Growth
Answers use the latest facts on this page and Qonfido’s peer-group tiers. They are research aids, not personalised investment advice. How ratings work
What is the NAV of Aditya Birla Sun Life Pharma and Healthcare Fund - Regular Plan - Growth today?
As of 2026-10-01, the NAV of Aditya Birla Sun Life Pharma and Healthcare Fund - Regular Plan - Growth shown on Qonfido is ₹35.52. Mutual fund NAVs are typically published for each market day; always check the as-of date before acting.
Is Aditya Birla Sun Life Pharma and Healthcare Fund - Regular Plan - Growth a good fund?
Qonfido currently places Aditya Birla Sun Life Pharma and Healthcare Fund - Regular Plan - Growth in the Select tier within the Healthcare Fund peer group. Select tier indicates solid peer-group quality with room to review fit for your goals. This is a peer-group research signal—not a buy recommendation, suitability assessment, or guarantee of future returns. See Qonfido’s fund rating methodology for how tiers are built and their limits.
Is Aditya Birla Sun Life Pharma and Healthcare Fund - Regular Plan - Growth a good fit for me?
Whether Aditya Birla Sun Life Pharma and Healthcare Fund - Regular Plan - Growth is a good fit depends on your goals, risk tolerance, time horizon, tax situation, and the rest of your portfolio—not on a single fund page. Qonfido does not provide personalised SEBI-registered investment advice here. Use AI Fund Discovery to explore alternatives, or consult a licensed advisor for suitability.
What is the 3-year return of Aditya Birla Sun Life Pharma and Healthcare Fund - Regular Plan - Growth?
The 3-year CAGR shown for Aditya Birla Sun Life Pharma and Healthcare Fund - Regular Plan - Growth on Qonfido is 18.7% (category average about 18.4% for Healthcare Fund where available). Past performance is not indicative of future results and does not mean the fund is suitable for you.
Which category does Aditya Birla Sun Life Pharma and Healthcare Fund - Regular Plan - Growth belong to?
Aditya Birla Sun Life Pharma and Healthcare Fund - Regular Plan - Growth is a Healthcare Fund scheme from Aditya Birla Sun Life Mutual Fund. Explore the Healthcare Fund category page on Qonfido to compare peers within the same SEBI group.
How can I explore Aditya Birla Sun Life Pharma and Healthcare Fund - Regular Plan - Growth further on Qonfido?
Reported fund size (AUM) for Aditya Birla Sun Life Pharma and Healthcare Fund - Regular Plan - Growth is about ₹739 Cr. AUM is context only and does not predict returns. On Qonfido you can review the fact card, open related best-fund hubs, try the SIP calculator with this scheme, or ask AI Fund Discovery for peer comparisons—still as research support, not personalised advice.
Similar Funds in Healthcare Fund
Explore Aditya Birla Sun Life Mutual Fund
See schemes, AUM, Qonfido Premier picks, and ask Qonfido about this fund house.